Expression of Human Transferrin in Rice Grain
人转铁蛋白在水稻籽粒中的表达
基本信息
- 批准号:7609000
- 负责人:
- 金额:$ 11.96万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-02-01 至 2010-01-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdverse effectsAnimalsBiological ProductsBloodBlood-Borne PathogensBone callusCell Culture TechniquesCell physiologyCellsCerealsClinical TrialsCodon NucleotidesCulture MediaDevelopmentDrug CarriersDrug Delivery SystemsDrug IndustryEndocytosis PathwayEventFoundationsFutureGrowthHumanIn TransferrinIndustryIronIron binding capacity measurementLactoferrinMammalian CellMarketingMeasuresMuramidaseNamesOrganismPharmaceutical PreparationsPhasePlantsPlasmaPlayPriceProcessProductionProteinsQuality ControlRecombinant ProteinsRecombinantsRelative (related person)ResearchRiceRiskRoleSafetySeedsSerum AlbuminSiteSmall Business Innovation Research GrantSourceSystemTF geneTechnologyTherapeutic IndexTimeTransferrinTransferrin ReceptorTransgenic OrganismsVascular blood supplyWeightWorkYeastscell growthcostdrug candidatedrug efficacyhigh riskinnovationlarge scale productionnext generationpathogenpublic health relevancereceptor mediated endocytosisscale uptherapeutic vaccineuptake
项目摘要
DESCRIPTION (provided by applicant): Transferrin is an essential ingredient used in cell culture media due to its crucial role in regulating cellular iron uptake, transport, and utilization, and also a promising drug carrier to increase drug therapeutic index via its unique transferrin receptor-mediated endocytosis pathway. Transferrin currently in use is made mainly from blood plasma, and thus it carries a high risk of contamination with blood-borne pathogens while facing blood supply shortage. Recombinant production of transferrin protein is ideally situated to address both the safety concern and shortage problem of native transferrin for use in cell culture and drug delivery markets. Currently only limited quantity of yeast cell-expressed recombinant human transferrin is available at an extremely high price in the cell culture market. Ventria Bioscience already has produced the human lactoferrin, a close relative to human transferrin, in rice grains on large scale and at low lost. In this proposal, we plan to exploit similar technology used for large scale production of lactoferrin to express human transferrin in rice grains. The proposed studies will develop stable transgenic rice lines expressing recombinant human transferrin as a safe and low cost alternative to human blood derived transferrin for use in biopharmaceutical cell culture and drug delivery markets. Public Health Relevance: Transferrin plays a crucial role in regulating iron and is an essential ingredient used in cell culture medium and a potential candidate for drug conjugates. Transferrin used in cell culture is currently made from blood plasma, and thus carries a high risk of contamination with pathogens. Development of an affordable animal free source of recombinant human transferrin would enable safe large scale use of transferrin in cell culture and drug conjugates.
产品描述(申请人提供):转铁蛋白是细胞培养基中的一种重要成分,因为其在调节细胞铁摄取、转运和利用方面具有关键作用,也是一种有前途的药物载体,通过其独特的转铁蛋白受体介导的内吞途径增加药物治疗指数。目前使用的转铁蛋白主要由血浆制成,因此当面临血液供应短缺时,它具有被血液传播的病原体污染的高风险。转铁蛋白的重组生产理想地解决了用于细胞培养和药物递送市场的天然转铁蛋白的安全性问题和短缺问题。目前,在细胞培养市场上,只有有限数量的酵母细胞表达的重组人转铁蛋白可以以极高的价格获得。Ventria Bioscience已经在大米中大规模生产了人乳铁蛋白,这是一种与人转铁蛋白密切相关的蛋白。在本研究中,我们计划利用类似于大规模生产乳铁蛋白的技术,在水稻中表达人转铁蛋白。拟议的研究将开发稳定的转基因水稻品系,表达重组人转铁蛋白,作为一种安全和低成本的替代人血来源的转铁蛋白,用于生物制药细胞培养和药物输送市场。公共卫生相关性:转铁蛋白在调节铁中起着至关重要的作用,是细胞培养基中使用的重要成分,也是药物缀合物的潜在候选者。细胞培养中使用的转铁蛋白目前由血浆制成,因此具有被病原体污染的高风险。开发负担得起的无动物来源的重组人转铁蛋白将使得转铁蛋白在细胞培养和药物缀合物中的安全大规模使用成为可能。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Expression, purification, and characterization of recombinant human transferrin from rice (Oryza sativa L.).
来自水稻 (Oryza sativa L.) 的重组人转铁蛋白的表达、纯化和表征。
- DOI:10.1016/j.pep.2010.04.019
- 发表时间:2010
- 期刊:
- 影响因子:1.6
- 作者:Zhang,Deshui;Nandi,Somen;Bryan,Paula;Pettit,Steve;Nguyen,Diane;Santos,MaryAnn;Huang,Ning
- 通讯作者:Huang,Ning
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Deshui Zhang其他文献
Deshui Zhang的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Deshui Zhang', 18)}}的其他基金
Low-cost proinsulin-transferrin fusion protein in rice for treatment of diabetes
大米中的低成本胰岛素原-转铁蛋白融合蛋白用于治疗糖尿病
- 批准号:
8454380 - 财政年份:2013
- 资助金额:
$ 11.96万 - 项目类别:
Recombinant production of human transferrin for cell culture
用于细胞培养的人转铁蛋白的重组生产
- 批准号:
7907022 - 财政年份:2009
- 资助金额:
$ 11.96万 - 项目类别:
Recombinant production of human transferrin for cell culture
用于细胞培养的人转铁蛋白的重组生产
- 批准号:
8075438 - 财政年份:2009
- 资助金额:
$ 11.96万 - 项目类别:
相似海外基金
Unraveling Adverse Effects of Checkpoint Inhibitors Using iPSC-derived Cardiac Organoids
使用 iPSC 衍生的心脏类器官揭示检查点抑制剂的副作用
- 批准号:
10591918 - 财政年份:2023
- 资助金额:
$ 11.96万 - 项目类别:
Optimization of mRNA-LNP vaccine for attenuating adverse effects and analysis of mechanism behind adverse effects
mRNA-LNP疫苗减轻不良反应的优化及不良反应机制分析
- 批准号:
23K15383 - 财政年份:2023
- 资助金额:
$ 11.96万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of adverse effects of combined exposure to low-dose chemicals in the living environment on allergic diseases and attempts to reduce allergy
阐明生活环境中低剂量化学品联合暴露对过敏性疾病的不良影响并尝试减少过敏
- 批准号:
23H03556 - 财政年份:2023
- 资助金额:
$ 11.96万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Green tea-based nano-enhancer as an adjuvant for amplified efficacy and reduced adverse effects in anti-angiogenic drug treatments
基于绿茶的纳米增强剂作为抗血管生成药物治疗中增强疗效并减少不良反应的佐剂
- 批准号:
23K17212 - 财政年份:2023
- 资助金额:
$ 11.96万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Effects of Tobacco Heating System on the male reproductive function and towards to the reduce of the adverse effects.
烟草加热系统对男性生殖功能的影响以及减少不利影响。
- 批准号:
22H03519 - 财政年份:2022
- 资助金额:
$ 11.96万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Mitigating the Adverse Effects of Ultrafines in Pressure Filtration of Oil Sands Tailings
减轻油砂尾矿压力过滤中超细粉的不利影响
- 批准号:
563657-2021 - 财政年份:2022
- 资助金额:
$ 11.96万 - 项目类别:
Alliance Grants
1/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
1/4-破译ECT结果和不良反应的机制(DECODE)
- 批准号:
10521849 - 财政年份:2022
- 资助金额:
$ 11.96万 - 项目类别:
4/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
4/4-破译ECT结果和不良反应的机制(DECODE)
- 批准号:
10671022 - 财政年份:2022
- 资助金额:
$ 11.96万 - 项目类别:
2/4 Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
2/4 ECT 结果和不良反应的破译机制(DECODE)
- 批准号:
10670918 - 财政年份:2022
- 资助金额:
$ 11.96万 - 项目类别:
Adverse Effects of Using Laser Diagnostics in High-Speed Compressible Flows
在高速可压缩流中使用激光诊断的不利影响
- 批准号:
RGPIN-2018-04753 - 财政年份:2022
- 资助金额:
$ 11.96万 - 项目类别:
Discovery Grants Program - Individual